Delivery Order SPE2DB22D1106-SPE2DB25FFAY5
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, valued at $1,184.52, with an ultimate completion date of August 4, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor and critical vendor for federal...
- AmerisourceBergen Drug Corp was awarded a $3,941.38 delivery order by the Defense Logistics Agency (DLA) on September 10, 2025, for the supply of Fluticasone Propionate HFA 220 mcg inhalers (12 grams). The contract is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively procured....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,948.50 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Fluticasone Propionate HFA 220 MCG inhalers (12 GM units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the vendor's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order is scheduled for completion by July 29, 2025, with performance based at the...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Fluticasone Propionate HFA 110 MCG inhalers in 12-gram quantities. This competitively awarded, non-set-aside contract has a ceiling value of $1,108.08 with a firm fixed price and an ultimate completion date of August 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the primary contractor for this delivery order under its...
- The Defense Logistics Agency awarded a delivery order valued at $3,545.00 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 MCG 12GM inhalers. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 4, 2025. The pharmaceutical products will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order is issued...
- On September 4, 2025, the Defense Logistics Agency awarded a delivery order contract valued at $8,680.24 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 220 microgram 12-gram inhalers. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 5, 2025. The contract will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $2,108.90 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Fluticasone Propionate HFA 110 mcg inhalers (12 grams), with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Fluticasone Propionate HFA 220 mcg inhalers (12 grams) with a ceiling value of $9,431.13. This non-set-aside, competitively awarded contract operates under firm fixed pricing and requires completion by June 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency's Medical Supply Chain awarded a $2,875.14 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Fluticasone Propionate HFA 220 mcg inhalers (12 grams). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,803.08 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Fluticasone Propionate HFA 220 mcg inhalers (12 grams). This non-competitive, firm fixed-price delivery order is scheduled for completion by August 7, 2025, with performance based in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical supplier to federal medical procurement needs,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAY5Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,336.38 by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Fluticasone Propionate HFA 220 MCG inhalers (12 grams). The contract represents a non-set-aside, competitively awarded delivery order with firm fixed pricing, reflecting standard federal procurement practices for pharmaceutical commodities. Performance is scheduled for completion by August 1, 2025, with the place of performance located in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999 and extending through December 2026. The IDC serves as a global vehicle enabling the contractor to supply a wide range of pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's extensive federal contract portfolio demonstrates significant capability in fulfilling competitive federal medical supply requirements across multiple therapeutic domains for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 7/31/25 |